Evgeny Chirshev

440 total citations
12 papers, 336 citations indexed

About

Evgeny Chirshev is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Evgeny Chirshev has authored 12 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Evgeny Chirshev's work include Cancer Cells and Metastasis (5 papers), MicroRNA in disease regulation (4 papers) and Tissue Engineering and Regenerative Medicine (3 papers). Evgeny Chirshev is often cited by papers focused on Cancer Cells and Metastasis (5 papers), MicroRNA in disease regulation (4 papers) and Tissue Engineering and Regenerative Medicine (3 papers). Evgeny Chirshev collaborates with scholars based in United States, France and South Korea. Evgeny Chirshev's co-authors include Juli Unternaehrer, Yevgeniya Ioffe, Kerby C. Oberg, Hanmin Wang, Carlotta A. Glackin, Sang M. Nguyen, Antonella Bertucci, Saied Mirshahidi, Shannalee R. Martinez and Jeffrey I. Zink and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

In The Last Decade

Evgeny Chirshev

11 papers receiving 335 citations

Peers

Evgeny Chirshev
Evgeny Chirshev
Citations per year, relative to Evgeny Chirshev Evgeny Chirshev (= 1×) peers Michela Coan

Countries citing papers authored by Evgeny Chirshev

Since Specialization
Citations

This map shows the geographic impact of Evgeny Chirshev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evgeny Chirshev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evgeny Chirshev more than expected).

Fields of papers citing papers by Evgeny Chirshev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evgeny Chirshev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evgeny Chirshev. The network helps show where Evgeny Chirshev may publish in the future.

Co-authorship network of co-authors of Evgeny Chirshev

This figure shows the co-authorship network connecting the top 25 collaborators of Evgeny Chirshev. A scholar is included among the top collaborators of Evgeny Chirshev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evgeny Chirshev. Evgeny Chirshev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Báez, Ineavely, Evgeny Chirshev, Shannalee R. Martinez, et al.. (2022). TSLP as a Potential Therapy in the Treatment of CRLF2 B Cell Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences. 24(1). 474–474. 3 indexed citations
2.
Liu, Qizhi, Stacey Chung, Bingchen Han, et al.. (2022). TOP1 inhibition induces bifurcated JNK/MYC signaling that dictates cancer cell sensitivity. International Journal of Biological Sciences. 18(10). 4203–4218.
3.
Chirshev, Evgeny, et al.. (2021). Let-7i Reduces Aggressive Phenotype and Induces BRCAness in Ovarian Cancer Cells. Cancers. 13(18). 4617–4617. 10 indexed citations
4.
Wang, Hanmin, Evgeny Chirshev, Antonella Bertucci, et al.. (2021). The Epithelial–Mesenchymal Transcription Factor SNAI1 Represses Transcription of the Tumor Suppressor miRNA let-7 in Cancer. Cancers. 13(6). 1469–1469. 24 indexed citations
5.
Chirshev, Evgeny, Antonella Bertucci, Hanmin Wang, et al.. (2020). Epithelial/mesenchymal heterogeneity of high‐grade serous ovarian carcinoma samples correlates with miRNA let‐7 levels and predicts tumor growth and metastasis. Molecular Oncology. 14(11). 2796–2813. 27 indexed citations
6.
Chirshev, Evgeny, Kerby C. Oberg, Yevgeniya Ioffe, & Juli Unternaehrer. (2019). Let7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer. SHILAP Revista de lepidopterología. 8(1). 24–24. 187 indexed citations
7.
Chirshev, Evgeny, et al.. (2019). Abstract TMIM-065: MICRO-RNA LET-7 REGULATION AND FUNCTION IN OVARIAN CANCER AND EARLY EMBRYONIC DEVELOPMENT. Clinical Cancer Research. 25(22_Supplement). TMIM–65. 1 indexed citations
8.
Wang, Hanmin, Evgeny Chirshev, Sang M. Nguyen, et al.. (2018). Snail knockdown reverses stemness and inhibits tumour growth in ovarian cancer. Scientific Reports. 8(1). 8704–8704. 59 indexed citations
10.
Wang, Hanmin, Evgeny Chirshev, Sang M. Nguyen, et al.. (2018). Abstract 1989: Mechanism of tumor suppressor miRNA let-7 downregulation in ovarian cancer: The epithelial-mesenchymal transition factor Snail is associated with stemness and represses let-7. Cancer Research. 78(13_Supplement). 1989–1989. 1 indexed citations
11.
Ross, Christina K. Cajigas‐Du, Shannalee R. Martinez, Sourav Roy, et al.. (2018). RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance. Oncotarget. 9(54). 30363–30384. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026